Lecture series explores AI in nursing
November 7, 2025
The School of Nursing kicked off its “AI in Action Collaborative Series” with a presentation on the evolving role of artificial intelligence in nursing education, research and practice.
Category
November 7, 2025
The School of Nursing kicked off its “AI in Action Collaborative Series” with a presentation on the evolving role of artificial intelligence in nursing education, research and practice.
October 30, 2025
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, Oct. 30, 2025 – Feeling tired can make exercise a challenge, especially with age. A new pilot clinical trial at UT Health San Antonio suggests that supplementing with branched-chain amino acids (BCAAs) alongside an exercise program may help reduce fatigue, improve strength, and ease symptoms of […]
October 28, 2025
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Honor highlights excellence in cancer care, research and innovation SAN ANTONIO, Oct. 28, 2025 – UT Health San Antonio’s Mays Cancer Center has been named among the nation’s leading hospitals and health systems for excellence in oncology programs, according to Becker’s Hospital Review. The publication’s annual list features more than […]
October 8, 2025
A leap forward in brain imaging is coming to San Antonio. UT Health San Antonio’s Center for Brain Health, opening in December 2025, will be the first in Texas to house a Siemens MAGNETOM 7-Tesla Terra.X magnetic resonance imaging (MRI) system — one of the most advanced MRI technologies available. This scanner produces ultra-high-resolution brain […]
October 3, 2025
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Content provided by Britny Rodriguez SAN ANTONIO, Oct. 3, 2025 – Teens in San Antonio and the surrounding areas will once again have access to Project YES, a free and anonymous online program that provides young people with new ways to care for their mental health. Part of UT Teen […]
October 3, 2025
University researchers have developed a promising compound that targets tumor cells while sparing healthy tissue. Their collaboration shows the power of multidisciplinary science that bridges dentistry, chemistry and commercialization to bring hope to patients.